Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jessie Durrand Hall"'
Autor:
Jin Xu, Michelle G. Goveia, Tomáš Marček, Jessie Durrand Hall, Timo Vesikari, Andrew W. Lee, Camilo J. Acosta, David R. Johnson
Publikováno v:
Human Vaccines & Immunotherapeutics
In randomized active-comparator controlled studies, DTaP5-HB-IPV-Hib showed comparable immunogenicity and safety to other licensed vaccines. This study assessed persistence of anti-hepatitis B surface antigen (HBs) and anti-pertussis antibodies, when
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35669abcc195e9a14e527eb9cbfcdbe6
https://doi.org/10.1080/21645515.2019.1673119
https://doi.org/10.1080/21645515.2019.1673119
Autor:
Zoran Popmihajlov, Michael Boeckh, Lei Pang, Drew J. Winston, Kimberly Hurtado, Vicki A. Morrison, Luis H. Camacho, Jessie Durrand Hall, Shu-Chih Su, Kathleen M. Mullane, Ann M. Arvin, Paula W. Annunziato, Susan S. Kaplan
Publikováno v:
Open Forum Infectious Diseases
Background In phase 3 trials, inactivated varicella zoster virus (VZV) vaccine (ZVIN) was well tolerated and efficacious against herpes zoster (HZ) in autologous hematopoietic stem cell transplant (auto-HSCT) recipients and patients with solid tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86f078c0e66a00175181ed00130146a3
http://europepmc.org/articles/PMC7336559
http://europepmc.org/articles/PMC7336559
Autor:
George J. Hanna, Laurent Alric, Vincent Leroy, Stanislas Pol, Dominique Larrey, Barbara Haber, Tarik Asselah, Michael N. Robertson, Christophe Hézode, Ernest Asante-Appiah, Deborah D. Brown, Feng-Hsiu Su, Véronique Loustaud-Ratti, Lawrence Serfaty, Eric Nguyen-Khac, Peggy Hwang, Jessie Durrand Hall, Jean-Pierre Bronowicki, Amir Guidoum, Albert Tran, Violaine Ozenne, Rohit Talwani, Si Nafa Si Ahmed, Karin Hagen
Publikováno v:
Liver International
Liver International, Wiley-Blackwell, 2020, 40 (5), pp.1042-1051. ⟨10.1111/liv.14313⟩
Liver International, Wiley-Blackwell, 2020, 40 (5), pp.1042-1051. ⟨10.1111/liv.14313⟩
International audience; Background & Aims Hepatitis C virus (HCV) genotype (GT) 4 infection is prevalent in sub-Saharan Africa and the Middle East, particularly in Egypt. This study evaluated the safety and efficacy of elbasvir/grazoprevir administer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c4661dfe96532cdabc04228e2db4487
https://hal-u-picardie.archives-ouvertes.fr/hal-03590858
https://hal-u-picardie.archives-ouvertes.fr/hal-03590858
